"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
FLOXURIDINE - INJECTION
COMMON BRAND NAME(S): FUDR
USES: Floxuridine is used to treat certain types of stomach/intestinal cancer that have spread to the liver. It is a chemotherapy drug that is used to slow or stop cancer cell growth.
HOW TO USE: This medication is given by injection into an artery using a continuous infusion pump. It is given through a catheter placed inside the artery that supplies blood to the tumor. This method directs the medication to the tumor so that it can have a stronger effect on the tumor with less risk of serious side effects in the rest of the body. When starting the first course of treatment with this medication, you should be in a hospital where you can be monitored for possible serious side effects.
This medication will be prepared and mixed for you by a health care professional. Dosage is based on your medical condition, weight, and response to treatment.
This medication should be used as long as you continue to benefit from the treatment. When serious side effects appear, your doctor will stop treatment with this medication. After the side effects have lessened, treatment will resume.
Additional Floxuridine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.